tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tara Bancroft, 25 are a BUY (86.21%), 4 are a HOLD (13.79%).
Analyst Tara Bancroft, currently employed at TD COWEN, carries an average stock price target met ratio of 45.89% that have a potential upside of 26.97% achieved within 103 days.
Tara Bancroft’s has documented 60 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics.
Analyst best performing recommendations are on PCVX (VAXCYTE).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX) at 6/14/2024. The price target of $7 was fulfilled within 26 days with a profit of $1.25 (21.74%) receiving and performance score of 8.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Jun-2021
$21.5
$-0.03 (-0.14%)
$27
7 months 12 days ago
(11-Mar-2026)
1/7 (14.29%)
$0.25 (1.18%)
42
Buy Since 15-Dec-2022
$21.5
$-0.03 (-0.14%)
$22
7 months 13 days ago
(10-Mar-2026)
1/17 (5.88%)
$0.22 (1.03%)
43
Buy Since 21-Jun-2021
$21.5
$-0.03 (-0.14%)
$30
7 months 14 days ago
(09-Mar-2026)
1/10 (10%)
$0.17 (0.80%)
44
Buy Since 27-Feb-2024
$21.5
$-0.03 (-0.14%)
$20
7 months 17 days ago
(06-Mar-2026)
2/6 (33.33%)
$0.3 (1.42%)
80
Buy Since 14-Dec-2022
$17
7 months 17 days ago
(06-Mar-2026)
3/20 (15%)
$6.07 (55.54%)
108
Which stock is Tara Bancroft most bullish on?
Which stock is Tara Bancroft most reserved on?
What Year was the first public recommendation made by Tara Bancroft?
